We are live on ! Find out more
NABL icon

N-able

202 hedge funds and large institutions have $1.43B invested in N-able in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 82 increasing their positions, 55 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 55

1.59% more ownership

Funds ownership: 96.68%98.27% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

3% less capital invested

Capital invested by funds: $1.48B → $1.43B (-$46.4M)

2% less funds holding

Funds holding: 207202 (-5)

12% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 33

Holders
202
Holders Change
-5
Holders Change %
-2.42%
% of All Funds
2.64%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
29
Increased
82
Reduced
55
Closed
33
Calls
$368K
Puts
Net Calls
+$368K
Net Calls Change
+$259K

NABL Hedge Fund Activity: Q3 2025 in Review

202 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in N-able (NABL) for Q3 2025, worth a combined $1.43B — down 3.1% from $1.48B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of NABL and 29 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 82 added.

The largest buyer was Macquarie Group, adding an estimated $18.3M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $4.13M sold.

  • 202 institutional investors held N-able (NABL) as of Q3 2025, down from 207 in Q2 2025.
  • Funds reported $1.43B of N-able stock for Q3 2025, down 3.1% quarter-over-quarter.
  • 29 funds opened new N-able positions in Q3 2025 and 33 closed out, a net change of -4 holders.
  • The largest N-able buyer in Q3 2025 was Macquarie Group, an estimated $18.3M added.
  • The largest N-able seller in Q3 2025 was Invenomic Capital Management, an estimated $4.13M sold.

Based on aggregated 13F filings for Q3 2025.